拜耳的农作物科学部门通过孟山都收购得到加强,是种子、农作物保护和数字农业技术领域的全球领导者,推动农业创新。
拜耳是一家主要的欧洲蓝筹股公司,涵盖农作物科学、药物和消费者健康领域,尽管面临孟山都收购带来的法律困扰,但提供多元化的生命科学敞口。
拜耳是全球处方药和生命科学领导者,发明了阿司匹林,现在生产广泛使用的消费者健康产品,包括Aleve、Claritin和Coppertone,以及处方药。
拜耳是一家全球生命科学公司,生产处方药、非处方健康产品和农业解决方案,最以发明阿司匹林而闻名。
拜耳是一家德国生命科学巨头,在农作物科学、药物和消费者健康领域拥有主要地位,但持续的孟山都相关诉讼仍然是投资者关注的主要问题。
Bayer AG is a diversified life sciences giant operating across pharmaceuticals, consumer health, and crop science (agriculture). The company's acquisition of Monsanto in 2018 made it a global leader in agricultural biotechnology, but the deal has proven enormously costly due to ongoing Roundup/glyphosate litigation, which has erased tens of billions in shareholder value.
Bull case: Bayer's Crop Science division is a world leader in seeds, traits, and crop protection, offering strong AgriTech exposure. The pharmaceutical pipeline includes promising oncology and cardiovascular assets. The stock trades at deeply depressed valuations, offering potential upside if litigation risk diminishes.
Bear case: Glyphosate liabilities remain a massive overhang with uncertain total costs. Key pharma blockbusters like Eylea and Xarelto face patent cliffs, threatening near-term revenue. Debt levels remain elevated post-Monsanto acquisition, and dividend sustainability is questionable. Management credibility has suffered after years of value destruction.
Bayer represents a classic deep-value turnaround play with significant risks. The AgriTech franchise remains world-class, but legal and pharmaceutical headwinds make this a high-conviction contrarian bet rather than a core holding.
Latest from Otrai
A stock index is a single number that summarizes the price action of a basket of companies. The S&P 500 tracks roughly 500 large US firms, the Nasdaq-100 tracks the 100 largest non-financial names on the Nasdaq exchange, and the Dow Jones Industrial Average follows 30 blue-chip stocks.
The Greeks explain why an option costs what it costs and how that price changes when the stock moves, time passes, and volatility shifts. Delta, Gamma, Theta, and Vega, made accessible.
Chart patterns are the most recognizable part of technical analysis and the most misunderstood. Most fail or break out the wrong way before reversing. This guide covers head and shoulders, double tops and bottoms, triangles, and flags — with realistic reliability, target measurement, and false-breakout confirmation.
每个交易员都有一个在脑子里看起来很好的策略。回测是您发现它是否实际有效的方式。以下是如何正确测试策略、哪些指标重要，以及为什么大多数回测结果好得不真实。
Powered by Rexiew